Evidence map›Paper›PMID 33383090›Full record

ArticleThe Journal of allergy and clinical immunology2021

Deletion of IL-4Rα signaling on B cells limits hyperresponsiveness depending on antigen load.

Sabelo Hadebe, Jermaine Khumalo, Sandisiwe Mangali, Nontobeko Mthembu, Hlumani Ndlovu, Martyna Scibiorek, Amkele Ngomti, Frank Kirstein, Frank Brombacher

Open access · hybridAbstract read
In one paragraph

Article in The Journal of allergy and clinical immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Adoptive Transfer of B Cells In Vivo for Assessment of Their Immune Function.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  5. Article
  6. Article
  7. Piecing Together the Role of IL-4 Receptor Alpha in Allergic Asthma One Cell at a Time.American journal of respiratory cell and molecular biology · 2024
    Article
  8. The association between eosinophils (CD16Dermatology and therapy · 2023
    Article
  9. Article
  10. Article
  11. B Cell IL-4 Drives Th2 ResponsesFrontiers in immunology · 2022
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Sabelo HadebeDivision of Immunology, and South African Medical Research Council Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Electronic address: sabelo.hadebe@uct.ac.za.
Jermaine KhumaloDivision of Immunology, and South African Medical Research Council Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; International Centre for Genetic Engineering and Biotechnology (ICGEB) and Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa.
Sandisiwe MangaliDivision of Immunology, and South African Medical Research Council Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; International Centre for Genetic Engineering and Biotechnology (ICGEB) and Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa.
Nontobeko MthembuDivision of Immunology, and South African Medical Research Council Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; International Centre for Genetic Engineering and Biotechnology (ICGEB) and Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa.
Hlumani NdlovuDivision of Chemical and Systems Biology, Department of Integrative Biomedical Sciences, Faculty of Health Sciences, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Martyna ScibiorekDivision of Immunology, and South African Medical Research Council Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; International Centre for Genetic Engineering and Biotechnology (ICGEB) and Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa.
Amkele NgomtiDivision of Immunology, and South African Medical Research Council Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; International Centre for Genetic Engineering and Biotechnology (ICGEB) and Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa.
Frank KirsteinDivision of Immunology, and South African Medical Research Council Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Frank BrombacherDivision of Immunology, and South African Medical Research Council Immunology of Infectious Diseases, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa; International Centre for Genetic Engineering and Biotechnology (ICGEB) and Institute of Infectious Diseases and Molecular Medicine (IDM), Division of Immunology, Health Science Faculty, University of Cape Town, Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Diseases and Molecular Medicine (IDM), Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. Electronic address: brombacherfrank@gmail.com.
University of Cape Town · ZAInternational Centre for Genetic Engineering and Biotechnology · ZASouth African Medical Research Council · ZA

Funding

Wellcome TrustWellcome Trust 203135Z/16/Z
6 · The paper itself

Abstract

backgroundB cells play an important role in allergies through secretion of IgE. IL-4 receptor α (IL-4Rα) is key in allergic asthma and regulates type 2 cytokine production, IgE secretion, and airway hyperresponsiveness. IL-4 activation of B cells is essential for class switching and contributes to the induction of B effector 2 (Be2) cells. The role of Be2 cells and signaling via IL-4Rα in B cells is not clearly defined.

objectiveWe sought to find out whether IL-4Rα-responsive B cells or Be2 function was essential in experimental allergic asthma.

methodsMice lacking IL-4Rα on B cells (mb1

resultsWe found that IL-4Rα signaling on B cells was important for optimal T

conclusionsIL-4Rα signaling on B cells is deleterious in allergic asthma because it is required for optimal T

Indexed as

AllergensAnimalsAntigensAsthmaB-LymphocytesHypersensitivityInterleukin-13Interleukin-4 Receptor alpha SubunitLungMiceMice, Inbred BALB CPneumoniaPyroglyphidaeRespiratory HypersensitivitySignal TransductionTh2 CellsAllergensAntigensInterleukin-13Interleukin-4 Receptor alpha SubunitB cellsB effector 2 cellsgerminal centerIL-4RαT follicular helper cellT(H)2 cells

Identifiers

PMID33383090
PMCPMC8253118
OpenAlexW3114538623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.